Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis

Figure 4 Encephalopathy after transjugular intrahepatic portosystemic stent. TIPSS-related hepatic encephalopathy (new onset or worsening from baseline) was noted in 11.7% (95%CI: 6.3%-17.2%) of the 198 patients in the 6 studies. There was, however, evidence of heterogeneity among the studies (P = 0.04). TIPSS indicates transjugular intrahepatic portosystemic stent shunt.